BioSpace News Archive

Under the $1.4 billion Project NextGen initiative, Regeneron was awarded a $326 million grant for its preventive monoclonal antibody, while Johnson & Johnson got $10 million to bankroll startups.

To successfully compete against one another and Big Pharma for top talent, biotech companies need to do a better job of selling themselves.

After identifying structural variations in the 19-gauge filter needle included in some eye injection kits, Apellis has advised doctors to only use 18-gauge kits already in circulation and that will be distributed.

Spurred by an “inadvertent” disclosure, Roche’s Genentech on Wednesday released interim and immature overall survival findings for its anti-TIGIT antibody tiragolumab in non-small cell lung cancer.

IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will hold a presentation in conjunction with the publication of the interim report for the period January-June 2023.

Since 2019 the International Centers for Precision Oncology is a German foundation working to enable growing numbers of Cancer Patients worldwide to get access to highly effective diagnostics and treatments in Radiomolecular Precision Oncology.

Telix Pharmaceuticals Limited announces its financial results for the half-year ended 30 June 2023.

BioArctic AB announced that the Japanese Patent Office is granting a new drug substance patent for the antibody BAN0805, invented by BioArctic as a potential treatment of Parkinson’s disease.

The heart teams at the Piedmont Heart Institute in Atlanta, Georgia, USA and the University of Virginia Health System in Charlottesville, VA, USA, successfully performed the first two implantations in the US of the Trisol Transcatheter Tricuspid Valve Replacement as part of a U.S. Food and Drug Administration approved Early Feasibility Study, led by Principal Investigator Isaac George, MD.

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization, announced a capacity update with the addition of three new Grade B cell therapy suites to its Longmont, CO facility.